Synthesis of 18Ffluoroalkyl esters of carfentanil - PowerPoint PPT Presentation

1 / 7
About This Presentation
Title:

Synthesis of 18Ffluoroalkyl esters of carfentanil

Description:

( pharmacological effect at 2 g/70kg patient) High specific activity required ... Unanswered questions in this paper: Does the agent provide a useful image? ... – PowerPoint PPT presentation

Number of Views:240
Avg rating:3.0/5.0
Slides: 8
Provided by: mikek75
Category:

less

Transcript and Presenter's Notes

Title: Synthesis of 18Ffluoroalkyl esters of carfentanil


1
Synthesis of 18Ffluoroalkyl esters of
carfentanil
  • 11CCarfentanil has several difficulties
  • Short half-life (20 min)
  • Extremely potent! (pharmacological effect at 2
    ?g/70kg patient)
  • High specific activity required
  • 740MBq (20mCi) administration ? 88.8TBq/mmol
    (2.40Ci/?mol)
  • Possible, but takes great care to achieve
  • A solid quality control method is required!

G. Henriksen et al, J Label Compd Radiopharm
2005, 48, 771-779.
2
Research Objectives
  • To synthesize two 18F-fluoroalkyl cafentanil
    derivatives
  • To stabilize the ester bond
  • To lower the toxicity profile
  • To improve the signal intensity of cafentanil PET
    studies

3
Fluoroalkyl Precursors
  • Prepared by standard reactions
  • Direct route to 1-2 fluoroiodoethane low yield
  • Tosyl and iodo fluoroethanes reacted with
    carfentanyl carboxylate

4
Fluoroethyl Carfentanil Optimization
  • DMF, 150oC, 20mM NaI, 15.9mM TBAF
  • Optimized
  • 368
  • gt97 RC purity
  • SA gt 35TBq/mmol

5
Fluoropropyl Carfentanil Optimization
  • DMF, 160oC, 15.9mM TBAF
  • Optimized
  • 62
  • gt97 RC purity
  • SA gt 27TBq/mmol

6
Are these Useful Imaging Compounds?
  • Unanswered questions in this paper
  • Does the agent provide a useful image?
  • Is it stable enough in vivo to bind to the
    receptor before degradation of the ester bond?
  • Does it accumulate in other organs to an extent
    that the image quality is degraded or that
    radiation dose accumulation becomes a problem?

Henrikson et al, Eur. J. Nuc. Med., 2004, S02,
S250. Henrikson et al, Biorg Med Chem Letters,
2005, 15, 1773-1777. Henrikson et al, Drug
Development Research, 2006, 67, 890-904.
7
Surprise!
  • Published before paper!
  • Good uptake 3.5-5.5 ID/g
  • Cerebral clearance too fast
  • Ester bond broken by esterases in the brain?
Write a Comment
User Comments (0)
About PowerShow.com